TREATING INSOMNIA - PHARMACOLOGICAL AND NONPHARMACOLOGICAL APPROACHES

被引:20
作者
BLIWISE, DL
机构
[1] Stanford University Medical Center, Stanford, CA, 94305, 211 Quarry Road
关键词
BENZODIAZEPINES; INSOMNIA; NONPHARMACOLOGICAL TREATMENTS; PHARMACOLOGICAL TREATMENTS; SEDATIVE-HYPNOTICS; VALERIAN;
D O I
10.1080/02791072.1991.10471604
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Insomnia is a commonly encountered condition in clinical practice. The prevalence of self-reported poor sleep increases with age and is more common in women. There are clear associations between poor sleep and psychiatric disturbance; however, causality in this regard may be complex, and there are at least some insomniacs who show high somatic tension without marked psychopathology. The development of chronic insomnia can be conceptualized as involving predisposing, precipitating, and perpetuating factors. Pharmacological treatments for insomnia most typically involve judicious and intermittent usage of a benzodiazepine hypnotic. A variety of such medications are available, with varying absorption and elimination characteristics. Benzodiazepines are preferred over antidepressants in the treatment of insomnia in individuals without major psychiatric disorder because of fewer side effects and a larger margin of safety. Nonpharmacological treatments typically rely on elements of sleep hygiene, stimulus control, sleep restriction, and chronotherapy. The establishment of good patient-clinician rapport and the working through of unfounded beliefs and unrealistic expectations of the sleep experience are also important components of the behavioral treatment of insomnia. Use of such techniques, particularly when combined in a treatment package, has shown appreciable benefits in improving sleep.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 31 条
  • [1] THE ZURICH STUDY .7. INSOMNIA - SYMPTOMS, CLASSIFICATION AND PREVALENCE
    ANGST, J
    VOLLRATH, M
    KOCH, R
    DOBLERMIKOLA, A
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1989, 238 (5-6) : 285 - 293
  • [2] [Anonymous], 1991, CASE STUDIES INSOMNI
  • [3] EFFECT OF VALERIAN ON HUMAN SLEEP
    BALDERER, G
    BORBELY, AA
    [J]. PSYCHOPHARMACOLOGY, 1985, 87 (04) : 406 - 409
  • [4] BALTER M, 1991, JUN PRESCR DRUG ISS
  • [5] BLIWISE DL, 1988, J CLIN PSYCHIAT, V49, P349
  • [6] BLIWISE DL, SOC SCI MED, P50
  • [7] BOOTZIN RR, 1976, BEHAVIOR THERAPY TEC
  • [8] CARSKADON MA, 1976, AM J PSYCHIAT, V133, P1382
  • [9] EPIDEMIOLOGIC-STUDY OF SLEEP DISTURBANCES AND PSYCHIATRIC-DISORDERS - AN OPPORTUNITY FOR PREVENTION
    FORD, DE
    KAMEROW, DB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (11): : 1479 - 1484
  • [10] GILLIN JC, 1990, NEW ENGL J MED, V322, P239